Abstract C46: NSABP FC-7: A phase Ib study evaluating neratinib (N) and cetuximab (Cmab) in patients (pts) with quadruple wild-type (quad wt) (KRAS/NRAS/BRAF/PI3KCA wt) metastatic... von Jacobs, Samuel A., Lee, James J., George, Thomas J., Wade, James L., Stella, Philip J., Wang, Ding, Sama, Ashwin R., Buyse, Marc E., Kanyuch, Jodi A., Srinivasan, Ashok, Pogue-Geile, Kay L., Kim, S. Rim, Wolmark, Norman, Allegra, Carmen J.

Volltext